BlaOXA-48 Genotypic Detection of Carbapenem Resistance in Isolates of Pseudomonas Aeruginosa
DOI:
https://doi.org/10.51985/JBUMDC2019133Abstract
Objective: To determine the prevalence of carbapenem resistance in strains of Pseudomonas aeruginosa at a molecular
level by detecting OXA-48 gene which transcribe for resistance to the antibiotic carbapenem among indoor patients of a
tertiary care hospital Karachi.
Study Design and Setting: This observational cross-sectional study was conducted from September 2018 to May 2019
at PNS Shifa hospital of Karachi.
Methodology: Total 140 strains of Pseudomonas aeruginosa were received and cultured from pus samples. These samples
were collected from different wards like medicine, surgery, burn unit, ICU, ENT, plastic surgery, paedriatic and family
ward. Carbapenem resistance was screened phenotypically by AST (Antibiotic susceptibility test), MHT (Modified Hodge
test) and mCIM (Modified Carbapenem Inactivation Method) in all samples. Only in resistant cases OXA-48 gene was
detected by real time PCR (polymerase chain reaction). Data was analyzed by following the proper loading sequence on
product specification sheet. Data was statistically analyzed by SPSS version 23.0. Results were expressed as frequencies
(percentages).
Results: Out of 140, 17 (12%) were found to be resistant to carbapenem by AST, 20 (14%) by MHT, 25 (17.8%) by mCIM.
Out of 25 resistant cases, 4 (16%) presence of OXA-48 gene by real time PCR were detected.
Conclusion: OXA-48 gene showed 16% carbapenem resistance in this study. Pseudomonas aeruginosa is an opportunistic
organism which causes multidrug resistance especially in hospitalized patients. Carbapenem is the last resort for serious
infections.
References
Ventola CL. The antibiotic resistance crisis: part 1: causes
and threats. Pharmacy and therapeutics. 2015; 40(4):277.
Chang HH, Cohen T, Grad YH, Hanage WP, O'Brien TF,
Lipsitch M. Origin and proliferation of multiple-drug resistance
in bacterial pathogens. Microbiol. Mol. Biol. Rev..
;79(1):101-16.
World Health Organization. Implementation manual to prevent
and control the spread of carbapenem-resistant organisms at
the national and health care facility level: interim practical
manual supporting implementation of the Guidelines for the
prevention and control of carbapenem-resistant Enterobacteriaceae,
Acinetobacter baumannii and Pseudomonas aeruginosa
in health care facilities. World Health Organization; 2019.
Zanganeh Z, Eftekhar F. Correlation of oxacillinase gene
carriage with the genetic fingerprints of imipenem-resistant
clinical isolates of Acinetobacter baumannii. JJM. 2015 8(9).
Codjoe FS, Donkor ES. Carbapenem resistance: a rev. Med
Sci. 2018; 6(1):1.
Aktaº Z, Kayacan ÇB, Schneider I, Can B, Midilli K,
Bauernfeind A. Carbapenem-hydrolyzing oxacillinase, OXA-
, persists in Klebsiellapneumoniae in Istanbul, Turkey.
Chemotherapy. 2008; 54(2):101-6.
Kazi M, Khot R, Shetty A, Rodrigues C. Rapid detection of
the commonly encountered carbapenemases (New Delhi
metallo- -lactamase, OXA-48/181) directly from various
clinical samples using multiplex real-time polymerase chain
reaction assay. IJMS. 2018 1;36(3):369.
Mohanty S, Maurya V, Gaind R, Deb M. Phenotypic
characterization and colistin susceptibilities of carbapenemresistant
of Pseudomonas aeruginosa and Acinetobacter spp.
The Journal of Infection in Developing Countries. 2013;
(11):880-7.
Guo L, An J, Ma Y, Ye L, Luo Y, Tao C, Yang J. Nosocomial
outbreak of OXA-48-producing Klebsiellapneumoniae in a
Chinese hospital: clonal transmission of ST147 and ST383.
PLoS One. 2016; 11(8):e0160754.
Moghadampour M, Rezaei A, Faghri J. The emergence of bla
OXA-48 and bla NDM among ESBL-producing
Klebsiellapneumoniae in clinical isolates of a tertiary hospital
in Iran. ActamicrobiologicaetimmunologicaHungarica. 2018;
(3):335-44.
Khatun R, Shamsuzzaman SM. Detection of OXA-181/OXA-
carbapenemase producing Enterobacteriaceae in
Bangladesh. Ibrahim Medical College Journal. 2015;9(2):45-
Bakthavatchalam YD, Anandan S, Veeraraghavan B.
Laboratory detection and clinical implication of oxacillinase-
like carbapenemase: the hidden threat. Journal of global
infectious diseases. 2016; 8(1):41.
Golle A, Janezic S, Rupnik M. Low overlap between
carbapenem resistant Pseudomonas aeruginosa genotypes
isolated from hospitalized patients and wastewater treatment
plants. PloS one. 2017; 12(10):e0186736.
Al-Ahmadi GJ, Roodsari RZ. Fast and specific detection of
Pseudomonas Aeruginosa from other pseudomonas species
by PCR. Annals of burns and fire disasters. 2016 31; 29(4):264.
Wenzler E. Feature Article Applying Fluoroquinolone
Pharmacokinetics, Pharmacodynamics, and Updated Clinical
Breakpoints for Gram-Negative Pathogens to Determine
Optimal Dosing. CLSI AST News Update.4 2019.
Song W, Hong SG, Yong D, Jeong SH, Kim HS, et al.
Combined use of the modified hodge test and carbapenemase
inhibition test for detection of carbapenemase-producing
Enterobacteriaceae and metallo- -lactamase-producing
Pseudomonas spp. Annals of laboratory medicine. 2015;
(2):212-9.
Walthall K, Anderson K, Reese N, Lonsway D, KamileRasheed
J, Karlsson M. Evaluation of the RAPIDEC CARBA NP,
Conventional CarbaNP, and the Modified Carbapenem
Inactivation Method (mCIM) Tests for Phenotypic Detection
of Carbapenemase-Producing Organisms. American Journal
of Clinical Pathology. 2018; 150(suppl_1):S123-4.Judd WR, Ratliff PD, Hickson RP, Stephens DM, Kennedy
CA. Clinical and economic impact of meropenem resistance
in Pseudomonas aeruginosa–infected patients. American
journal of infection control. 2016; 44(11):1275-9.
Buehrle DJ, Shields RK, Clarke LG, et al. Carbapenemresistant
Pseudomonas aeruginosa bacteremia: risk factors
for mortality and microbiologic treatment failure. Antimicrob
agents and chemother. 2017; 61(1):e01243-16.
Abbas SH, Naeem M, Adil M, Naz SM, Khan A, Khan MU.
Sensitivity patterns of Pseudomonas aeruginosa isolates
obtained from clinical specimens in Peshawar. Journal of
Ayub Medical College Abbottabad. 2015 ;27(2):329-32.
Pierce VM, Simner PJ, Lonsway DR, Roe-Carpenter DE,
Johnson JK, Brasso WB, et al. Modified carbapenem
inactivation method for phenotypic detection of carbapenemase
production among Enterobacteriaceae. Journal of clinical
microbiology. 2017; 55(8):2321-33.
Sfeir MM, Satlin MJ, Fauntleroy KA, et al. Blood-Modified
Carbapenem Inactivation Method (Blood-mCIM): a Phenotypic
Method for Detecting Carbapenemase-Producing
Enterobacteriaceae Directly from Positive Blood Culture
Broths. Journal of clinic microb. 2019.
Pawar S, Mohite ST, Datkhile K, et al. Closing the Gap
Between Phenotypic and Genotypic Detection of Carbapenem
Resistant Enterobacteriaceae by New Modified Carbapenem
Inactivation Method. J of Clin and Diag. Res. 2018; 12(11).
Baran I, Aksu N. Phenotypic and genotypic characteristics of
carbapenem-resistant Enterobacteriaceae in a tertiary-level
reference hospital in Turkey. Annals of clinical microbiology
and antimicrobials. 2016;15(1):20.
Bonnin RA, Bogaerts P, Girlich D, Huang TD, Dortet L, et
al. Molecular characterization of OXA-198 carbapenemaseproducing
Pseudomonas aeruginosa clinical isolates.
Antimicrobial agents and chemotherapy. 2018; 62(6):e02496-
Begum N, Shamsuzzaman SM. Emergence of carbapenemaseproducing
urinary isolates at a tertiary care hospital in Dhaka,
Bangladesh. Tzu Chi Medical Journal. 2016; 28(3):94-8.
Mohamed SE, Alobied A, Hussien WM, Saeed MI. blaOXA-
carbapenem resistant Pseudomonas aeruginosa clinical
isolates in Sudan. Journal of Advances in Microbiology.
:1-5.
Van der Zee A, Roorda L, Bosman G, Fluit AC, et al. Multicentre
evaluation of real-time multiplex PCR for detection of
carbapenemase genes OXA-48, VIM, IMP, NDM and KPC.
BMC infectious diseases. 2014; 14(1):27.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Shaista Bakhat; Yasmeen Taj; Faisal Hanif, Saman Nadeem
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
